அமெரிக்கா பங்கு ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Operator
Good day and thank you for standing by. Welcome to the Vanda Pharmaceuticals Inc Second Quarter 2021 Earnings Conference Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Kevin Moran, Vanda s Chief Financial Officer. Please go ahead.
Please go ahead.
Senior Vice President, Chief Financial Officer and Treasurer
Thank you, Joel. Good afternoon and thank you for joining us to discuss Vanda Pharmaceuticals Second Quarter 2021 performance. Our second quarter 2021 results released this afternoon and are available on the SEC s EDGAR system and on our website www.vandapharma.com. In addition, we are providing live and archived versions of this conference call on our website. Joining me on today s call is Dr. Mihael Polymeropoulos, our President, Chief Executive office and Chairman of the Board. Following my introductory remarks, Mihael will update you on our ongoing activities. I will then comment on our financial r ....

United States , Olivia Brayer , Mihaelh Polymeropoulos , Mihael Polymeropoulos , Kevin Moran , Vanda Pharmaceuticals Inc , America Equity Research , Vanda Pharmaceuticals Inc Second Quarter , Olivia Brayer Bank , Vanda Pharmaceuticals Second Quarter , Chief Financial , Vice President , Chief Financial Officer , Chief Executive , Regarding Forward Looking Statements , Risk Factors , Financial Condition , Annual Report , Smith Magenis Syndrome , Hour Sleep Wake Disorder , ஒன்றுபட்டது மாநிலங்களில் , ஒலிவியா பிரேயர் , கெவின் மோரன் , வந்தா மருந்துகள் இன்க் , அமெரிக்கா பங்கு ஆராய்ச்சி , ஒலிவியா பிரேயர் வங்கி ,